Does NC Medicaid Cover Wegovy? Yes — Here's Who Qualifies in 2026

Affiliate disclosure: The RX Index may earn a commission from marked provider links. Commissions never change the government sources, coverage findings, or editorial conclusions on this page. We earn nothing on the main path described here.

Published: August 21, 2026 · Last reviewed: August 21, 2026 · Last verified: August 21, 2026 · By The RX Index Research Team

Does NC Medicaid cover Wegovy? Yes. NC Medicaid covers Wegovy for weight management. It was cut on October 1, 2025 and put back on December 12, 2025, which is why so many websites still say it isn't covered. Your prescriber has to get prior approval first. If you're approved, you pay up to $4 per prescription — or $0 if a copay exemption applies.

That's the answer. Now here's the dated detail almost nobody tells you: through September 30, 2026, Wegovy is preferred for weight management and Zepbound is not. NC Medicaid has already posted its next drug list, and Zepbound becomes preferred on October 1, 2026. That changes what you should ask your prescriber for depending on when the request goes in.

Below is every rule NC Medicaid actually applies, in plain English: who may qualify, what your prescriber has to send, the two paperwork mistakes that can sink a first request, what to do when the pharmacy says no, and how to appeal. We pulled all of it from NC Medicaid's own documents, the current and next drug lists, and current FDA labels, and we date-stamped every one.

Best next step if you already have NC Medicaid: Jump to the one-page request checklist. It is more useful for you than a paid provider link.

Is this page for you?

The 30-second version

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

But if you have NC Medicaid, provider matching is not your first move. Use your benefit. Start with the NC Medicaid Wegovy request checklist, your own Medicaid prescriber, and a pharmacy that accepts your plan.

Does NC Medicaid cover Wegovy in 2026?

Yes. NC Medicaid covers Wegovy for weight management as of August 21, 2026. Coverage was removed on October 1, 2025 and restored effective December 12, 2025 under a directive from the Governor. Coverage applies to NC Medicaid Direct and NC Medicaid Managed Care. Prior approval is still required. Wegovy is preferred under the current July 2026 drug list and remains preferred under the already-posted October 2026 list.

Let's define two terms, because the rest of the page uses them constantly.

Preferred Drug List (PDL) is NC Medicaid's list of favored medicines. A preferred drug normally has an easier formulary path than a non-preferred drug. It does not mean the prescription is approved automatically.

Prior approval — also called prior authorization, or PA — means your prescriber has to send NC Medicaid a request showing why you meet the coverage rules before the pharmacy can fill the medicine as covered.

So the honest full answer is: covered, preferred, and still conditional. A prescription alone will not get you Wegovy in North Carolina. A prescription plus a complete prior approval request may.

The date split that changes the answer

This is not a forecast. NC Medicaid has already posted the October 2026 Preferred Drug List, and its change log says Zepbound pen and vial move from non-preferred to preferred. NC Medicaid's July 2026 panel minutes state that the update becomes effective October 1, 2026. The current July 2026 Preferred Drug List still lists Wegovy as preferred and Zepbound as non-preferred.

Why “preferred” is a bigger deal than it sounds

Many national GLP-1 articles treat Zepbound as the first choice and Wegovy as the fallback. In North Carolina, that is not the current coverage order through September 30, 2026.

NC Medicaid's December 2025 restoration bulletin is blunt about the current rule: members must try and fail preferred Wegovy — or have a documented reason they cannot take it — before the state will approve non-preferred Zepbound or Saxenda for weight management.

So if your request is being processed before October 1, 2026 and you ask for Zepbound first, you are asking for the slower formulary path. Wegovy is the fast one.

After the October list takes effect, that advice changes: both Wegovy and Zepbound are preferred. Your prescriber still has to choose the right drug and submit prior approval, but a Zepbound request should not be denied merely because Wegovy was not tried first under the old preferred-status rule.

Why do so many websites still say NC Medicaid doesn't cover Wegovy?

Because it was briefly true. NC Medicaid ended coverage of GLP-1s for weight management on October 1, 2025, citing a state funding shortfall, then restored it effective December 12, 2025. Pages written during that ten-week gap can still show the old answer. The December 2025 restoration bulletin replaced the October exclusion for weight management.

This is the single most confusing thing about this question, so here is the whole timeline with dates you can check yourself.

The reversal, receipt by receipt

Ten weeks. That's how long the “no” was true. But the internet does not have a delete button, and stale pages survive.

We're not telling you that to dunk on anybody. We're telling you because you may have already read an old answer, and if you did, you may have quietly given up on something you can still ask NC Medicaid to cover.

NC Medicaid is not the NC State Health Plan

If you're a teacher, a state employee, or a retiree, this next part is for you — and the answer is different.

Two programs. Two answers. If your insurance card says State Health Plan, this page will not fix that benefit and we'd rather say so now than waste your afternoon.

Who qualifies for Wegovy under NC Medicaid?

For the weight-management path, adults may meet the BMI threshold with a BMI of 30 or higher, or a BMI of 27 or higher plus at least one weight-related condition such as high blood pressure, type 2 diabetes, obstructive sleep apnea, cardiovascular disease, or dyslipidemia. Ages 12 to 17 may meet the threshold at the 95th BMI percentile for age and sex, at a BMI of 30, or at the 85th percentile with a severe weight-related condition. Baseline weight and BMI must be measured within 45 days of the request. Meeting a BMI threshold does not replace the rest of the prior-approval review.

Weight management is the main door, but it is not the only one. NC Medicaid has five GLP-1 coverage paths, plus the federal EPSDT medical-necessity review for members under 21.

We built this table by combining NC Medicaid's restored weight-management criteria, its current drug lists, its non-weight-indication bulletin, and the current FDA labels. That matters because one old state document still contains non-weight rules that NC Medicaid later removed.

The five GLP-1 coverage paths in North Carolina

MASH stands for metabolic dysfunction-associated steatohepatitis — fatty liver disease with inflammation and scarring. F2 and F3 mean moderate to advanced fibrosis. The current FDA-approved Wegovy use is not for F1 disease.

Two things worth pulling out of that table:

The current non-weight rule is the FDA label, not the old state checklist. NC Medicaid removed its earlier detailed heart, liver, and sleep-apnea criteria in November 2025 while it prepares updated criteria. That is why this page does not repeat the old age-45 rule, old test menu, alcohol cutoffs, or an F1 MASH claim as if they still control.

The under-21 override is real and it is federal. If a child misses an ordinary policy box, EPSDT changes the review to medical necessity. It is not automatic approval. The prescriber still has to explain how the treatment would correct, improve, or keep the child's condition from getting worse, and prior approval still applies.

What if your BMI is between 27 and 29.9?

Straight answer: that number alone will not do it. You also need a documented weight-related condition — high blood pressure, type 2 diabetes, sleep apnea, cardiovascular disease, or dyslipidemia.

If you have one of those and it is in your chart, you meet the BMI-and-condition threshold. You still need the current weight, lifestyle documentation, medication review, age-appropriate product, and safety review. If you think you might have a related condition but nobody has checked, raise that at the same visit. A blood pressure reading and a lipid panel are ordinary care.

What can stop or redirect a request

Your prescriber will check for these before submitting:

• The requested form is not FDA-approved for the member's age or use — for example, Wegovy tablets are not established for people under 18, and the tablet is not the MASH product
• A personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia syndrome type 2 (MEN2)
• A prior serious allergic reaction to semaglutide or a Wegovy ingredient
• Pregnancy, plans for pregnancy, or breastfeeding, which require formulation- and indication-specific medical decisions under the current FDA label
• Use of another semaglutide product or another GLP-1 receptor agonist at the same time

That last one catches people off guard. NC Medicaid's weight-management criteria do not allow the requested drug to be used with another GLP-1. If you are on Ozempic for diabetes, that has to be sorted out before a Wegovy request goes in.

Does the weight-management path sound like your situation? Use the request checklist below and bring it to the visit. It follows the actual documentation sequence without sending you to a paid program.

How much does Wegovy cost with NC Medicaid?

NC Medicaid's prescription copay is up to $4 per prescription, not $4 per month as a guaranteed flat price. Members under 21 and several other groups or services are exempt. NC Medicaid charges no monthly premium. Wegovy's manufacturer list price is $1,349.02 per package before rebates, discounts, insurance, or self-pay offers.

Here is the number that makes this whole page worth your time.

Up to $48 across twelve covered fills instead of a $16,188.24 list-price benchmark. That's not a discount. That's a different universe.

The $0 exemptions are broader than age alone. NC Medicaid lists hospice members, federally recognized tribal members or people using Indian Health Services, foster-care members, certain institutional members, some waiver and long-term-support members, and several exempt services. Pregnancy, childbirth, and postpartum services are exempt when related to that care; that does not turn Wegovy for weight loss into a pregnancy treatment.

You cannot be turned away at the counter only because you do not have $4

This is a real protection and almost nobody knows it exists.

NC Medicaid's current pharmacy manual says a pharmacy may not refuse service because a member cannot pay the copay. If the prescription is otherwise covered and approved, “I do not have four dollars right now” is not, by itself, a reason to send you home empty-handed.

You may still owe the $4. But inability to pay it at that moment cannot be the only reason for refusing the covered service.

If a pharmacist tells you otherwise, ask them politely to check the NC Medicaid copay rule or call the plan's pharmacy line. It may be a register or claim-setting problem rather than a true coverage denial.

Can you use the Wegovy savings card?

No. Novo Nordisk's commercial savings offer excludes people enrolled in Medicaid, Medicare, VA, DOD, TRICARE, and similar government prescription programs.

You do not need it for an approved Medicaid fill. A commercial coupon cannot beat a $0 or $4 Medicaid prescription.

How do you actually get NC Medicaid to approve Wegovy?

Your prescriber submits a prior-approval request with a recent weight and BMI, the qualifying route, lifestyle documentation, a medication review, and the safety information the form asks for. As of May 2, 2026, NC Medicaid Direct pharmacy prior approvals go to Prime Therapeutics, which processes submissions 24 hours a day, 7 days a week, 365 days a year. Managed Care members use their own health plan's process.

A request can stall even when the member meets the medical threshold. The two common reasons are simple: the file is incomplete, or it went to the wrong processor.

Let's fix both.

Step 1: Know which NC Medicaid you have

Look at your card. The plan changes where the paperwork goes — not whether the statewide weight-management benefit exists.

Every number above is from NC Medicaid's own utilization-management bulletin dated August 10, 2026.

A note if you're looking for WellCare: it is no longer a separate NC Medicaid plan. WellCare and Carolina Complete Health merged on April 1, 2026, and the combined plan uses the Carolina Complete Health name.

Step 2: Know that the Direct process changed in May 2026

If you have NC Medicaid Direct, this matters and your prescriber's office may not have caught it yet.

On May 2, 2026, NC Medicaid moved Direct pharmacy prior approvals to Prime Therapeutics. New Direct pharmacy requests go through Prime. NC Medicaid told providers to stop using the old NCTracks pharmacy-benefit functions for this work.

The good news buried in that change: Prime processes prior-approval submissions 24 hours a day, 7 days a week, 365 days a year. Weekends included.

So if a front-desk person tells you “we sent the pharmacy PA through the old NCTracks workflow” or “nothing is processed until Monday,” ask them to check the May 2026 change. That old route can cost you days.

Step 3: Bring these things to your appointment

This is the whole ballgame, and it is short.

1. A weight and BMI measured no more than 45 days before the request. A same-day measurement is cleanest.
2. The qualifying route, named correctly. That can be BMI 30+ by itself, or BMI 27+ with a named condition such as hypertension or dyslipidemia.
3. What you have been doing. The criteria ask for structured nutrition and physical activity, unless physical activity is not clinically appropriate. It does not have to be a program you paid for. It has to be documented.
4. A full medication list. The request must show that the new drug will not be combined with another GLP-1.
5. The exact product and form. “Wegovy” is not enough if age or indication changes whether the pen or tablet is FDA-approved.

NC Medicaid Wegovy request checklist

Use this as a one-page prep sheet. Check each box before the request goes out.

• [ ] I confirmed whether I have NC Medicaid Direct, a Standard Plan, a Tailored Plan, or Healthy Blue Care Together.
• [ ] My weight and BMI were measured within the last 45 days.
• [ ] My chart states the right qualifying route: BMI 30+, or BMI 27+ plus a named weight-related condition, or the age-12-to-17 growth-chart route.
• [ ] My chart documents structured nutrition and physical activity, or explains why activity is not clinically appropriate.
• [ ] My prescriber reviewed every GLP-1, semaglutide, tirzepatide, and diabetes medicine I take.
• [ ] The requested product is FDA-approved for my age and intended use.
• [ ] My prescriber checked the PDL date: Wegovy-first rules apply to non-preferred Zepbound through September 30, 2026; the posted October 2026 PDL makes Zepbound preferred.
• [ ] The request went to the right plan or Prime Therapeutics — not an old pharmacy workflow.
• [ ] I wrote down the submission date, reference number, and approval end date.

The two mistakes that can sink a first request

Mistake #1: the 45-day weigh-in.

NC Medicaid's restored weight-management criteria require baseline weight and BMI to be measured within 45 days of the request being submitted. A number from a physical three months ago does not meet that rule — even if it was accurate, even if your weight has gone up since.

This is one of the most avoidable reasons a valid request can be sent back for more information.

The fix: get weighed at the visit where you ask, and ask the office to submit that week. If the office is slow, call and ask when it went out.

Mistake #2: using the wrong preferred-drug rule for the date.

Through September 30, 2026, a Zepbound request for weight management generally requires an adequate Wegovy trial of three to six months, or a documented reason the member cannot take Wegovy. A rough couple of weeks is not the trial described in the restored criteria.

Read that again. Before October, asking for the current non-preferred drug can add months to the timeline.

But do not carry that advice past its expiration date. The posted October 2026 PDL moves Zepbound to preferred. For claims under that list, your prescriber should not be told to complete the old Wegovy-first step merely because Zepbound used to be non-preferred.

How fast should a decision come?

NC Medicaid's published standard for prescription-drug prior approvals is a decision within 24 hours of receiving the request. The state also says a delay can happen when it needs more information.

That is why “Did they receive it, and what exact item is missing?” is the best question to ask when you call. Write down the date, who you spoke to, and any reference number.

Before you leave the appointment: ask the office where the request is going, when it will be sent, and who will call you if the reviewer asks for more information. That three-question micro-commitment prevents days of silent waiting.

Can your health plan add its own extra rules?

For this PDL category, generally no. NC Medicaid's August 10, 2026 bulletin says Managed Care plans may add their own prior-authorization rules when the state has not set criteria and has not barred extra rules. The current and October weight-management GLP-1 categories carry the state's red notice that plans may not add utilization management or prior-authorization criteria to the category.

This is the part of the page we're proudest of, because it protects you and almost nobody publishes it.

A lot of insurance articles tell readers that each Managed Care plan can invent its own hoops. In North Carolina, for this drug category, that is not how the posted policy works.

NC Medicaid's August 10, 2026 bulletin says each PDL category carries red text when Managed Care plans may not add extra utilization management. The weight-management GLP-1 category has that red text on both the current July list and the posted October list: “Plans may not apply additional utilization management or prior authorization criteria to this category.”

What this means for you, in one sentence: if your plan tells you it needs a medical step that is not in the state's applicable criteria or PDL rule, that is worth questioning.

You do not have to argue. You can just ask: “Can you show me the state or plan criterion that requires that step? The NC Medicaid PDL says plans may not add extra utilization management to this category.”

Often it is a paperwork mix-up, an old form, or the wrong effective-date list. But knowing the rule exists changes the conversation.

One honest limit: your plan still controls the form, the portal, the fax or phone route, and the way it communicates a decision. A different submission process is not the same thing as a different medical rule. Do not confuse the two.

The pharmacy said no. What does that actually mean?

A pharmacy claim rejection and a formal prior-approval denial are different problems with different fixes. Common counter rejections mean no approval is attached to the claim, an approval expired, the claim went to the wrong processor, the product is non-preferred under the effective PDL, or the refill timing is off. A true clinical denial comes with a written notice, a reason, and appeal instructions.

Here's the trap: “not covered” at the register does not always mean the benefit excludes Wegovy.

What the pharmacy actually told you

Ask the pharmacist for the exact words or code on the screen. Not their summary — the message itself. Then you will know which row you are in, and each row has a different fix.

A 72-hour emergency supply exists — but the state's two instructions conflict

This is federal law, it is badly underused, and the implementation record is not as clean as it should be.

Federal Medicaid law requires a 72-hour emergency supply to be available for covered outpatient drugs that need prior approval in a qualifying emergency. NC Medicaid's May 4, 2026 launch bulletin says a pharmacy can use Submission Clarification Code 13, that copays may apply, and that there is no limit on how many times the emergency supply can be used.

Prime Therapeutics' current NC Medicaid Direct pharmacy manual says something different. It tells the pharmacy to use Level of Service 3 — Emergency, limits the benefit to one emergency fill per product and strength in 30 days, and tells pharmacies to call 844-620-6116 about an unbreakable package.

Those are two current state-published instructions that do not match. We are not going to pick one and pretend the other does not exist.

Three honest caveats, because we're not going to oversell this:

1. This is an emergency-supply rule, not a routine free starter fill. The pharmacy and plan must treat the situation as a qualifying emergency.
2. This section is most directly documented for NC Medicaid Direct. Managed Care plans can have their own claim route.
3. Wegovy is commonly dispensed in a package built around weekly dosing, which does not divide neatly into a 72-hour supply. The Prime manual specifically tells pharmacies to call about unbreakable packages.

So do not walk in demanding a specific billing code. Ask: “Is an emergency supply available while the prior approval is pending, and can you call the plan or Prime to confirm the current claim instructions for this package?”

The worst answer is no. The best answer is that the pharmacist finds a valid route without guessing.

Got a rejection you cannot decode? Use the table above, call the number on your Medicaid card, and ask for the exact claim code plus the exact next action. A paid provider link will not solve a claim routed to the wrong plan.

What if NC Medicaid denies your Wegovy request?

A denial can be appealed, and an incomplete request can often be corrected and resubmitted instead. The current Prime manual says NC Medicaid Direct members may request a State Fair Hearing within 30 days, excluding holidays, from receiving the denial letter. Managed Care members generally appeal to their health plan first within 60 days of the adverse-benefit notice. The deadline and instructions printed on your actual notice control.

First, a distinction that saves people weeks.

A fixable denial is not the same as a real no. If the reason was a stale weight, a missing diagnosis, the wrong product-status rule, or a document that never made it into the file, the fastest path may be a corrected submission rather than a full appeal.

Appeals are for when you disagree with the decision or need formal review. Resubmissions are for when the decision was made on incomplete or wrong information. Your notice and plan can tell you whether a corrected request is allowed while an appeal window is open.

If you were denied between October and December 2025 — ask for a new review

This one's important.

Every prior approval for weight-management GLP-1s stopped being valid after September 30, 2025. If a request was denied only because the weight-management benefit was excluded during the ten-week gap, that exclusion no longer controls a new request.

Ask your prescriber for a new request under the restored criteria, with a fresh weight and the current PDL. Do not assume an old denial means you still fail today's rules.

If the old notice still has a live appeal deadline or included another clinical reason, read it before choosing between a new request and an appeal. The paper in your hand controls the deadline.

If you've been assuming for the better part of a year that you do not qualify, this paragraph is the whole reason we built this page.

If you have NC Medicaid Direct

1. Read the denial letter and find the stated deadline. The current Prime pharmacy manual says 30 days, excluding holidays, from the date you receive it.
2. Match your proof to the exact reason: current weight and BMI with dates, qualifying diagnosis, lifestyle documentation, medication list, age-appropriate form, or the correct PDL date.
3. Follow the State Fair Hearing instructions printed on the notice.
4. Keep proof of when and how you submitted everything.

If you have a Standard Plan, Tailored Plan, or specialty plan

1. Appeal to the health plan first — generally within 60 days of the adverse-benefit notice.
2. Use the address, portal, fax, or phone route on the notice.
3. Send documents that answer the specific reason given, not a stack of unrelated records.
4. If the plan upholds the denial, the resolution notice explains the next fair-hearing step.

Do not use the Direct deadline if you are in a Managed Care plan, or the Managed Care deadline if you are in Direct. The notice in your hand controls.

Free help exists, and it is neutral

The NC Medicaid Ombudsman helps members understand notices and solve problems they could not resolve with a provider or health plan. Call 877-201-3750, Monday through Friday, 8 a.m. to 5 p.m., except state holidays.

They do not replace your appeal deadline. Call while you still have time to act.

For members under 21: say the word EPSDT

If the person denied is under 21, ask whether the request received an EPSDT review — the federal medical-necessity review that can go beyond ordinary policy limits for children and young adults.

Prior approval is still required. But the question can change from “Do they tick every ordinary policy box?” to “Is this treatment medically necessary to correct, improve, maintain, or prevent this child's condition from getting worse?”

That is a different question, and sometimes it gets a different answer.

Can you get Zepbound or Ozempic instead?

Yes, but the answer depends on the drug, the diagnosis, and the date. Through September 30, 2026, Zepbound is covered but non-preferred for weight management, so the current rule generally calls for a three-to-six-month Wegovy trial or a documented reason Wegovy cannot be used. Under the posted October 1, 2026 PDL, Zepbound becomes preferred. Ozempic and Rybelsus are diabetes drugs on the Medicaid list, not weight-only substitutes for Wegovy.

A clarification that matters: Ozempic is not the NC Medicaid weight-management door. It is FDA-approved and listed for type 2 diabetes. Wegovy contains the same active ingredient, semaglutide, but it has different FDA-approved uses, strengths, forms, and coverage rules. Asking for Ozempic “for weight loss” is asking the plan to use the wrong door.

The pen versus the tablet

Both the Wegovy pen and the Wegovy tablet are listed as preferred on the current and October NC Medicaid drug lists. But they are not interchangeable prescriptions. They use different dosing, and the FDA label limits them differently.

• The Wegovy injection is FDA-approved for weight management in adults and in children age 12 and older with obesity.
• The Wegovy tablet is FDA-approved for adult weight management and adult cardiovascular-risk reduction. Its safety and effectiveness have not been established in people under 18.
• The MASH indication is for Wegovy injection, not the tablet.

NC Medicaid's restored weight-management criteria were written before the newer tablet and say the requested product must be FDA-approved for the member's age, indication, and dosing. That is the clean rule to use. We'd rather tell you exactly where the form matters than guess on your behalf.

How long does approval last, and what happens at renewal?

For the restored weight-management pathway, NC Medicaid approves an initial six months, then renews in twelve-month blocks with no stated limit on the number of renewals. Renewal generally requires maintained weight loss of at least 5% of pretreatment weight for adults, or a BMI reduction greater than 4% for adolescents. The criteria also allow a prescriber to document a significant maintained reduction with a clinical rationale when those exact numbers are not met.

These time periods come from the weight-management criteria. Do not assume the same approval length controls Wegovy for heart-risk reduction or MASH, or Zepbound for sleep apnea; those non-weight uses are currently reviewed under the FDA label while updated state criteria are pending.

Three things to write down on day one, because they become your renewal baseline:

• Your starting weight and the date
• Your starting BMI and the date
• Your approval expiration date

The math, plainly

Adults: the main benchmark is at least 5% of starting weight lost and maintained.

If you started at 240 pounds, 5% is 12 pounds. A weight of 228 pounds is a 5% loss.

The formula, if you like formulas: (starting weight − current weight) ÷ starting weight × 100.

Adolescents: the main benchmark is a BMI reduction of more than 4%, maintained.

What if you are close but not quite there?

Here's a detail that is easy to miss, and it is genuinely good news.

NC Medicaid's restored criteria include a third option. If a prescriber documents a significant maintained reduction with a clinical rationale — even where the 5% or 4% benchmark is not met — that can support renewal.

It is not automatic. But it exists. And if you are close and panicking, the right move is not to give up. It is to ask your prescriber to document the actual change, why it matters clinically, and why continuation is reasonable.

Start renewals early. Check your expiration date, get the needed measurements before it hits, and ask the plan when it will accept the renewal. Nobody should lose momentum over a calendar.

Could NC Medicaid stop covering Wegovy again?

Yes, because weight-management drug coverage is an optional Medicaid benefit and North Carolina already removed it once over funding. But there is no posted October 2026 cut. The official October drug list keeps Wegovy preferred and adds Zepbound as preferred. The known October change expands preferred choices; it does not end the benefit.

We're not going to pretend this is settled forever, because you'd find out on your own and then you'd stop trusting us.

Weight-management drug coverage is optional under federal Medicaid rules. States can add it and states can drop it. North Carolina did both inside eighteen months.

Two practical things follow from that:

One: if you meet the rules, do not wait for a website to feel certain forever. Not because of hype or a fake deadline — because the benefit has changed before, and a complete request can be reviewed under the rules in force now.

Two: bookmark the source, not just this page. NC Medicaid posts drug lists and bulletins before websites catch up. We re-verify this article and show the date at the top, but the state's record is the source of truth.

The October 2026 PDL is already public. It keeps Wegovy pen and tablet preferred and moves Zepbound pen and vial from non-preferred to preferred on October 1, 2026. A list marked effective October is not the rule for an August or September claim, which is why this page gives both answers instead of blending them.

What real people are running into

We looked for North Carolinians talking about this in their own words, because the official documents do not capture what it actually feels like.

On one public Medicaid discussion thread, a North Carolina member asked:

“Has anyone had any luck getting nc medicaid to cover wegovy for weightloss only since the reinstated?!”

Another North Carolina commenter described the process in three words:

“A complete nightmare!!!”

We're including these for one reason: if you feel like you cannot get a straight answer, you're not imagining the confusion and you're not alone. The state changed the weight-management benefit twice in 2025, moved Direct pharmacy work to a new administrator in 2026, and now has a second drug-list change coming on October 1.

These comments show administrative frustration. They do not establish the coverage rule, they do not predict your result, and they say nothing about whether the medicine works. That is what the sourced sections above are for.

What if NC Medicaid isn't going to work for you?

Readers who do not have NC Medicaid, have moved out of state, or have reached the end of their applicable review and appeal path may need a commercial-insurance or self-pay option. FDA-approved brand-name medicines and compounded products are legally and regulatorily distinct and should be evaluated separately, not treated as the same product.

Time for the part most sites will not say out loud.

The RX Index makes money when readers start a paid online weight-loss program. This page does not do that for us — on purpose.

If you have NC Medicaid and your Wegovy request is approved, an up-to-$4 prescription beats every paid membership we could send you to. Not by a little. Ro's ongoing monthly membership alone is $149, more than 37 times a $4 fill, before medication. We're not going to insult you by pretending that competes with your Medicaid benefit. Go to your own Medicaid prescriber.

But here's the thing: because we're not selling you a subscription on the main path, we could spend the whole page on the paperwork that actually decides your answer. That's the trade. We think it is the right one.

Now — if none of the above applies to you, here's the honest landscape:

If you do not have Medicaid, your paths are commercial insurance or self-pay, and they price very differently. Ro (affiliate link) is one FDA-approved brand-name path. Ro's provider membership is $39 for the first month, then $149 month to month, or as low as $74 per month with a 12-month plan prepaid annually. Medication is extra. Ro currently offers access to FDA-approved options including Wegovy, Zepbound, and Foundayo, but the drug price depends on the product, dose, insurance, and any current cash-pay offer.

One thing to know before you click: Ro says patients with Medicaid and some other government-funded plans are not eligible for treatment through Ro. Medicare, Medicare supplement, and TRICARE members may still be eligible for certain cash-pay options, but Ro does not bill the membership fee to insurance. If you have NC Medicaid, that link is not for you. Use your benefit.

If you're not sure which non-Medicaid path fits, do not guess. Find My GLP-1 Path asks about your state, coverage, preferred form, and budget, then shows pricing for paths that may apply.

A compliance note we will not skip: FDA-approved medicines like Wegovy and Zepbound and compounded products are not the same thing and are not regulated the same way. We keep them separate and never present a compounded product as an FDA-approved substitute. If you are weighing a compounded option, read our compounded GLP-1 guidance first and go in informed.

Before you start: safety basics

Coverage approval is an administrative decision and is not a medical recommendation. Wegovy carries a boxed warning about thyroid C-cell tumors seen in rodents. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma, people with MEN2, and people with a prior serious hypersensitivity reaction to semaglutide or a Wegovy ingredient. Only a licensed clinician can determine whether it is appropriate for a given person.

We're going to keep this short and stay in our lane.

NC Medicaid saying yes means the paperwork cleared. It does not mean the medicine is right for your body. Those are two completely different judgments, made by two different parties.

Things to raise with your prescriber before you start:

• Any personal or family history of medullary thyroid cancer, or MEN2
• Any prior serious allergic reaction to semaglutide
• Pregnancy, breastfeeding, or plans to become pregnant
• Every other medicine you take, including diabetes medicines and any other GLP-1 or semaglutide product
• A history of pancreatitis, gallbladder problems, kidney problems, or diabetic eye disease
• Planned surgery or deep sedation, because Wegovy slows stomach emptying
• What side effects to expect early, and what warrants a call or urgent care

For weight reduction or cardiovascular-risk reduction, the FDA label says Wegovy should be stopped when pregnancy is recognized and stopped at least two months before a planned pregnancy. Breastfeeding guidance differs by form: breastfeeding is not recommended with the tablet, while the injection label says to discuss the benefits and possible risks with the clinician.

For the complete safety information, read the current FDA prescribing information for Wegovy. It is the primary source, it is free, and it is more complete than any article — including this one.

This page explains coverage rules. It does not diagnose, recommend a dose, or tell anyone to start or stop a medicine.

What we actually verified

Verified August 21, 2026. Here's exactly what we read, so you can check us.

Provider-stated versus independently checked

What remains formulation-specific: NC Medicaid's restored weight-management criteria predate the newer Wegovy tablet. The criteria say the product must be FDA-approved for the member's age, indication, and dosing. We therefore apply the current FDA label — tablet for adults only, injection for age 12 and older, MASH injection only — rather than inventing a tablet rule the state has not published separately.

How this page was made: we compared NC Medicaid's bulletins, current and future drug lists, restored prior-approval criteria, current provider manual, plan contacts, copay policy, appeal materials, FDA labels, manufacturer terms, and provider pricing. No physician reviewed this article, and we're not going to pretend one did. Every medical or coverage statement here is traced to a named primary source or routed back to the reader's own clinician and plan.

Found something out of date? Tell us and we'll fix it. Coverage rules move faster than websites.

Frequently asked questions

Does NC Medicaid cover Wegovy for weight loss? Yes. Coverage was restored effective December 12, 2025 and remains active as of August 21, 2026. Your prescriber must obtain prior approval, and the request must meet the applicable clinical criteria.

Do I need diabetes to get Wegovy covered in North Carolina? No. Weight management is its own coverage path. An adult may meet the BMI threshold at 30 or higher, or at 27 or higher with one documented weight-related condition.

How much does Wegovy cost with NC Medicaid? Up to $4 per covered prescription, not a separate monthly premium. It is $0 for members under 21 and for other members or services that qualify for a copay exemption.

Does NC Medicaid cover Wegovy for teenagers? The Wegovy injection can be covered from age 12 under the weight-management pathway when the member meets the age-specific rules. The Wegovy tablet is adult-only. Members under 21 also have the federal EPSDT medical-necessity review.

How long does prior approval take? NC Medicaid's published drug-PA standard is a decision within 24 hours of receiving the request. The state warns that missing information can delay the decision. Prime processes Direct submissions 24 hours a day, every day.

How long does a weight-management approval last? Six months for the first approval, then twelve months per renewal, with no stated limit on the number of renewals under the restored weight-management criteria.

What if I do not lose 5%? The criteria let a prescriber document a significant maintained reduction with a clinical rationale even when an adult does not reach 5% or an adolescent does not reach the 4% BMI benchmark. Ask the prescriber to include the actual change and the rationale.

Can I use an online telehealth company with NC Medicaid? Cash-pay telehealth memberships usually do not bill Medicaid. Ask the company before paying. Your lowest-cost path is a prescriber and pharmacy that accept your NC Medicaid plan; Ro specifically says Medicaid patients are not eligible for treatment through Ro.

Does NC Medicaid cover the Wegovy tablet? The current July and posted October PDLs list the Wegovy tablet as preferred. It is FDA-approved for adults, not people under 18, and it is not the FDA-approved Wegovy form for MASH. Prior approval still applies.

Does NC Medicaid cover Zepbound? Yes. Through September 30, 2026 it is non-preferred for weight management, so a Wegovy trial or documented exception generally applies. Under the posted October 1, 2026 PDL, Zepbound becomes preferred. It is also the FDA-approved GLP-1 option for adults with obesity and moderate-to-severe obstructive sleep apnea.

Does NC Medicaid cover Ozempic for weight loss? Ozempic is listed in the type 2 diabetes class, not as the weight-management product. For weight management, use the obesity-drug criteria and an age-appropriate product such as Wegovy or Zepbound.

Why did NC Medicaid stop covering Wegovy in 2025? NC Medicaid ended weight-management GLP-1 coverage effective October 1, 2025, citing a shortfall in state funding. Coverage was restored effective December 12, 2025.

I was denied in late 2025. Should I appeal? Ask for a current review first if the only reason was the temporary benefit exclusion. Old approvals stopped after September 30, 2025, and that exclusion no longer controls new requests. But read the notice: a live appeal deadline or a separate clinical reason can change the right move.

Is NC Medicaid the same as the NC State Health Plan? No. They are separate programs. The State Health Plan ended routine GLP-1 coverage for weight loss on April 1, 2024; NC Medicaid restored its weight-management benefit in December 2025.

What if I have both Medicare and NC Medicaid? Prescription coverage generally runs through Medicare first. Since July 1, 2026, eligible Part D members can use the Medicare GLP-1 Bridge for certain weight-management drugs at a $50 copay through December 31, 2027. The Bridge runs outside the normal Part D payment flow, and CMS says the $50 does not receive the low-income subsidy. Start with our Medicare and Wegovy guide and call the number on your Medicare drug card.

Can the pharmacy refuse to fill it if I cannot pay the $4? The current NC Medicaid pharmacy manual says a pharmacy may not refuse service because a member cannot pay the copay. The prescription still must be covered and otherwise payable, and you may still owe the copay.

What changes on October 1, 2026? The posted October PDL keeps Wegovy preferred and moves Zepbound to preferred. The old non-preferred Zepbound requirement to try Wegovy first should not be carried into claims under the new list, though prior approval and clinical rules remain.

Where to go next

If you have NC Medicaid and you fit the weight-management path, your next step is a prescriber appointment, a weight and BMI measured within 45 days, a documented qualifying route, and a request sent to the right plan. That's genuinely it. The system is more open than old web pages have been telling you.

Before the request goes out, use the NC Medicaid Wegovy request checklist. After it goes out, ask for the submission date and reference number. Those are the two moments where a small action prevents a long delay.

If you are somewhere in between — wrong state, no Medicaid, or at the end of your appeal path — you have other paths too. They cost more, and they deserve a real comparison rather than a guess.

No NC Medicaid and still not sure which GLP-1 path fits? Take the free 60-second matching quiz.

Sources

1. NC Medicaid, “NC Medicaid to Reinstitute Coverage of GLP-1s for Weight Management,” December 19, 2025
2. NC Medicaid, “NC Medicaid to Change Coverage for GLP-1 Weight Management Medications,” September 5, 2025
3. NC Medicaid, “Updates to NC Medicaid Coverage for Wegovy and Zepbound for Clinical Indications Other than Weight Loss,” November 4, 2025
4. NC Medicaid, Outpatient Pharmacy Prior Approval Criteria — GLP-1s for Weight Management
5. NC Medicaid Preferred Drug List, effective July 2026, revised July 24, 2026
6. NC Medicaid Preferred Drug List, effective October 2026
7. NC Medicaid Preferred Drug List Review Panel Minutes, July 9, 2026
8. NC Medicaid, “Pharmacy Benefit Administrator: Now Live for NC Medicaid Direct,” May 4, 2026
9. NC Medicaid, “Utilization Management by NC Medicaid Managed Care Health Plans — August 2026,” August 10, 2026
10. NC Medicaid, Copays
11. NC Medicaid Direct Pharmacy Provider Manual
12. NC Medicaid, Prior Approval and Due Process
13. Social Security Act § 1927 — Medicaid outpatient drug prior-authorization emergency supply
14. Social Security Act § 1905(r) — EPSDT
15. U.S. Food and Drug Administration, current Wegovy prescribing information
16. U.S. Food and Drug Administration, current Zepbound prescribing information
17. NovoCare, Wegovy list price
18. NovoCare, Wegovy Savings Offer terms
19. NC State Health Plan, January 25, 2024 board presentation on GLP-1 weight-loss coverage
20. NC Medicaid, WellCare and Carolina Complete Health merger
21. NC Medicaid Ombudsman
22. CMS, Medicare GLP-1 Bridge
23. Ro, Weight Loss Program Pricing
24. Ro, How Insurance Works with the Ro Body Membership
25. Reddit r/Medicaid, North Carolina Wegovy coverage discussion
26. Reddit r/Wegovy, North Carolina Medicaid member discussion